Enhanced care: Clinical Trials

3 trials of Enhanced care, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 active not recruiting. 3 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Active not recruiting 1
Phase 11Completed 1
Phase 31Completed 1

Follow Enhanced care: new trials by email Literature Review of Enhanced care trials Research Report on Enhanced care

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation
Potlako intervention, Enhanced care - Neoplasms, Hiv
Phase 2Active not recruitingBrigham and Women's Hospital8742020-11-182025-12-31
Treating the Partners of Drug Using Pregnant Women: Stage II
Enhanced care, control - Drug Addiction
Phase 2 / Phase 3CompletedJohns Hopkins University1582005-10-012013-03-05
Evaluating the Effectiveness of Family-Focused Psychoeducation in Treating Adolescents With Bipolar Disorder
Family-focused therapy for adolescents, Enhanced care - Bipolar Disorder
Phase 1 / Phase 2CompletedUniversity of California, Los Angeles582001-07-012014-03-26

Conditions studied

Acquired Immunodeficiency Syndrome (1)  ·  Anus Neoplasms (1)  ·  Bipolar Disorder (1)  ·  Breast Neoplasms (1)  ·  Neoplasms (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)  ·  Substance-Related Disorders (1)  ·  Uterine Cervical Neoplasms (1)  ·  Vulvar Neoplasms (1)

Sponsors

Brigham and Women's Hospital (1)  ·  Johns Hopkins University (1)  ·  University of California, Los Angeles (1)

Countries

United States (2)  ·  Botswana (1)

Top investigators

David A. Axelson, MD (1)  ·  David J. Miklowitz, PhD (1)  ·  Hendree Jones, PhD (1)  ·  Scott Dryden-Peterson, MD, MSc (1)

Results publications

PMID 18762591, PMID 19454920, PMID 21410418, PMID 22221277, PMID 23157895

NIH funding

R01CA236546 (1), R01DA013496 (1), R21MH062555 (1)